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Abstract
Perioperative goal-directed therapy is considered to improve patient outcomes after high-risk surgery. The association 
of compliance with perioperative goal-directed therapy protocols and postoperative outcomes is unclear. The purpose of 
this study is to determine the effect of protocol compliance on postoperative outcomes following high-risk surgery, after 
implementation of a perioperative goal-directed therapy protocol. Through a before-after study design, patients undergoing 
elective high-risk surgery before (before-group) and after implementation of a perioperative goal-directed therapy protocol 
(after-group) were included. Perioperative goal-directed therapy in the after-group consisted of optimized stroke volume 
variation or stroke volume index and optimized cardiac index. Additionally, the association of protocol compliance with 
postoperative complications when using perioperative goal-directed therapy was assessed. High protocol compliance was 
defined as ≥ 85% of the procedure time spent within the individual targets. The difference in complications during the first 
30 postoperative days before and after implementation of the protocol was assessed. In the before-group, 214 patients were 
included and 193 patients in the after-group. The number of complications was higher in the before-group compared to the 
after-group (n = 414 vs. 282; p = 0.031). In the after-group, patients with high protocol compliance for stroke volume vari-
ation or stroke volume index had less complications compared to patients with low protocol compliance for stroke volume 
variation or stroke volume index (n = 187 vs. 90; p = 0.01). Protocol compliance by the attending clinicians is essential and 
should be monitored to facilitate an improvement in postoperative outcomes desired by the implementation of perioperative 
goal-directed therapy protocols.
Keywords Perioperative goal-directed therapy · High-risk surgery · Before-after study · Protocol compliance
1 Introduction
Perioperative goal-directed therapy (pGDT) aims to opti-
mize the patient`s hemodynamic status using interven-
tions to reach predefined target values in the perioperative 
period [1]. These interventions include administering fluids, 
inotropes, and vasopressors, and are ultimately directed at 
improving oxygen delivery to organs. pGDT is considered to 
reduce postoperative complications and length of stay after 
high-risk surgery (HRS) [2–5]. Hence, the use of pGDT 
is recommended by several national guidelines, is part of 
early recovery after surgery (ERAS) guidelines, and has 
been included in the European Society of Anaesthesiology 
guideline for non-cardiac surgery [6–10].
Despite such recommendations, pGDT is not yet rou-
tinely implemented in clinical practice [11]. One explana-
tory factor for this discrepancy might be that clinical het-
erogeneity among trials troubles a clear interpretation of 
trials evaluating pGDT protocols [12]. Additionally, the 
term “goal-directed therapy” is poorly defined and is used 
to describe different treatment strategies in studies with 
varying degrees of complexity [13]. Furthermore, the suc-
cessful implementation of a multimodal protocol does not 
necessarily translate into improved usage of a protocol 
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Fig. 1  pGDT protocol 1. SVV Stroke volume variation, CI cardiac index. Both variables were obtained by using the EV1000 monitoring system, 
utilizing uncalibrated pulse-wave contour analysis
The protocol was implemented with the following considerations:
[14]. Quality improvement programs allow evaluation of 
new monitoring and treatment strategies such as pGDT in 
clinical practice. However, the importance of protocol com-
pliance, i.e., whether the treating clinician applies pGDT 
and achieves the hemodynamic targets in the individual 
patient, is unclear, since most studies that have evalu-
ated the effect(s) of pGDT either reported a high overall 
protocol compliance or did not record compliance at all 
[15–18].
The lack of evidence on the effective use of pGDT by clini-
cians may further contribute to the uncertainty as to whether 
pGDT protocols improve postoperative outcomes in clinical 
practice. We implemented a quality improvement program 
in which a pGDT protocol was introduced as an addition to 
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clinical practice for patients undergoing HRS. As we have 
expressed previously, such a ‘before and after’ model allows 
evaluating the effectiveness of pGDT under real-life condi-
tions [19]. We hypothesized that high compliance with a pGDT 
protocol improves postoperative outcomes compared to low 
compliance. While we assumed that the implementation of a 
pGDT algorithm would decrease the incidence of postoperative 
complications in patients undergoing HRS in our hospital, we 
secondarily assessed whether high pGDT protocol compliance 
contributed to further reduction in postoperative complications.
2  Methods
2.1  Study design and patients
The Local Research Ethics Committee approved the study 
and waived the need for consent since the pGDT protocol 
was considered clinical practice for patients undergoing 
elective HRS in our hospital. The study, undertaken at an 
academic teaching hospital was set-up using a before-after 
design [19]. In the before-group, data were retrospectively 
collected from patients who underwent HRS before the 
implementation of the pGDT protocol (August 2013 to 
February 2015). In the after-group, data were prospectively 
collected from patients undergoing HRS after the implemen-
tation of the pGDT protocol (July 2015 to February 2018). 
Patients in the after-group were compared to historical 
matched control patients in the before-group who underwent 
the same surgical procedure. Five major surgical procedures 
were included for analyzing the effects of the implementa-
tion of pGDT: pylorus-preserving pancreaticoduodenectomy 
(PPPD), abdominoperineal resection (APR), open abdomi-
nal aortic aneurysm repair (open AAA), open esophageal 
resection, and femoral-popliteal artery repair. Patients 
younger than 18 years, pregnant patients, (partly) thoraco-
scopic or laparoscopic procedures, and patients undergo-
ing emergency surgery were excluded from this study. This 
manuscript adheres to the SQUIRE guidelines [20].
2.2  pGDT protocol and anesthetic management
A 4-month training period (January 2015 to May 2015) was 
used to train caregivers (anesthesiologists and anesthesia 
nurses) in the pGDT treatment algorithms and associated 
monitoring methods before implementing pGDT. The train-
ing was done by giving lectures and hands-on training—using 
active learning methods during several internal meetings—
on how to optimize the patient`s hemodynamic status using 
stroke volume variation (SVV), cardiac index (CI), and stroke 
volume index (SVI). In short, the pGDT protocol consists 
of two treatment algorithms, based on the applicability of 
SVV-guided assessment of fluid responsiveness. Applicability 
of SVV depends on the presence of sinus rhythm, absence of 
significant valvular heart disease, and the absence of conges-
tive heart failure [21]. The patients’ lungs were mechanically 
ventilated in a volume-controlled mode with tidal volumes 
set at ≥ 8 ml  kg− 1. The SVV-guided treatment algorithm 
(pGDT1; Fig. 1) was primarily based on SVV and cardiac 
index (CI). The alternative algorithm (pGDT2, see Supple-
mentary Figure) was used when SVV guidance was rendered 
invalid (which, for example, included periods of open chest 
conditions and one-lung ventilation during esophageal resec-
tion) and was primarily based on stroke volume index (SVI) 
and CI. Both pGDT treatment algorithms propose the use of 
intravenous fluids (colloids or crystalloids) to improve SVV 
or SVI, and dobutamine to further augment CI. Caregivers 
using one of the pGDT treatment algorithms were recom-
mended to improve SVV or SVI first, and CI second, i.e. after 
SVV (pGDT treatment algorithm 1)/SVI (pGDT treatment 
algorithm 2) was within the set target. If the patient was unre-
sponsive to (repeated) fluid bolus administration while the CI 
target was not reached, the caregiver was recommended to 
increase CI. The SVI threshold in the 2nd treatment algorithm 
was set at 35 ml  m− 2, as based on previous studies [22, 23]. 
In our institution, the target MAP threshold generally used by 
caregivers is 65 mmHg, in patients undergoing non-cardiac 
surgery; nevertheless, it was left at the discretion of the attend-
ing anesthesiologist and no further specific recommendations 
were made in the after group. In all patients, a 20 g radial 
artery catheter was placed for continuous monitoring of blood 
pressure. The arterial catheter was connected to the FloTrac/
EV1000 monitoring system (Edwards Lifesciences, Irvine 
CA, USA), which uses uncalibrated pulse-wave analysis to 
calculate SVI, CI and SVV [24].
As the before-group served as a historical control group 
for which data were collected retrospectively, hemody-
namic management—including the selection, dosing, 
and timing of fluids, vasopressors, and inotropes, mode 
of mechanical ventilation—was at the discretion of the 
attending anesthesiologist.
In both the before-group and the after-group, general 
anesthesia and/or epidural analgesia was induced and main-
tained according to institutional practice and was left at the 
discretion of the attending anesthesiologist. In all patients, 
depth of anesthesia monitoring was applied using bispec-
tral index monitoring (BIS; Aspect Medical Systems, Nor-
wood, MA, USA) and BIS was targeted between 40 and 60 
throughout the procedure.
After the procedure was completed, patients from both 
groups were transferred to the intensive care unit (ICU) for 
postoperative care or to the post-anesthetic care unit (PACU) 
for extended postoperative monitoring. All patients were 
treated following enhanced recovery guidelines during pre-, 
per- and postoperative setting if applicable. There were, to 
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the best of our knowledge, no major changes in pre- or post-
operative care in any of these protocols during the conduct 
of the study.
2.3  Data collection
All pre-, intra- and postoperative data were gathered using 
our electronic medical record database, retrospectively in the 
before-group and prospectively in the after-group. The col-
lected data included preoperative information such as age, 
gender, height, weight and procedure type, as well as all 
relevant continuous intraoperative data from the anesthe-
sia monitor and ventilator, together with data on the use of 
intravenous fluids and medication (anesthetic agents, vaso-
pressors, inotropes), and the procedure duration, amount of 
intraoperative blood loss and urine production. Data from 
the FloTrac/EV1000 monitor were separately collected and 
after careful synchronization, added to the study database. 
Postoperative complications during the first 30 postopera-
tive days were also gathered from the electronic patient data 
management system and classified based on the ‘Expanded 
Accordion Severity Classification Model’ (see later).
2.4  Outcomes 
The primary outcome of this before-after study was the 
effect of pGDT protocol compliance on the incidence of 
postoperative complications. Postoperative complications 
were graded according to the ‘Expanded Accordion Sever-
ity Classification Model’, which has six grades of severity: 
mild, moderate, severe complications without need for gen-
eral anesthesia, severe complications with a need for general 
anesthesia, organ failure and postoperative death within 60 
days after the procedure [25]. The severity of the compli-
cations was given using points ranging from one point for 
mild complications to six points for postoperative death. 
The cumulative score was used to quantify postoperative 
complications.
Protocol compliance was determined by analyzing the 
total time SVV, SVI and CI were within the predefined tar-
get of the two pGDT treatment algorithms. SVV/SVI and 
CI were analyzed separately using time-weighted averages. 
High protocol compliance with SVV/SVI or with CI was 
defined as ≥85%, based on the assumption that the caregiver 
is familiar with the pGDT protocol: this cut-off point takes 
into account sudden changes in hemodynamic stability that 
are inherent to HRS under routine clinical circumstances.
2.5  Statistical analysis
SPSS 23.0 for Windows (IBM SPSS Statistics, IBM Corpo-
ration, Armonk, NY) was used for the statistical analyses. 
Descriptive analyses were performed for all variables. 
Continuous variables are reported as mean with standard 
deviation for parametric data or median with interquar-
tile range for non-parametric data. Categorical data are 
reported as numbers (with percentages). An independent 
sample t-test was used to analyze the parametric data and 
the Mann-Whitney U test was used for non-parametric data. 
Chi-square or Fisher’s exact test was performed to analyze 
categorical data. P-values below 0.05 were considered sta-
tistically significant, while the Bonferroni correction was 




In total, 429 patients were eligible for this study, of which 
214 were included in the before-group and 215 were 
screened for the after-group. In the after-group, 22 patients 
were excluded due to participation in conflicting interven-
tional studies, intraoperative conversion from curative to 
palliative care, or technical difficulties (Fig. 2). Finally, 193 
patients in the after-group were included and suitable for 
analysis, of which 188 patients had sufficient data for pro-
tocol compliance analysis. 153 patients (79%) were treated 
according to the SVV-based pGDT treatment algorithm 
(pGDT 1), of which in 5 patients hemodynamic data could 
not be retrieved. These patients were excluded from the 
protocol compliance analysis. Forty patients (21%) were 
treated according to the SVI-based pGDT treatment algo-
rithm (pGDT 2).
No relevant differences existed in patient characteristics 
between the before-group and the after-group (Table 1).
3.2  Intraoperative hemodynamic management
No differences between both groups with respect to the use of 
crystalloids were observed (Table 1). Although colloids were 
used in a comparable number of patients, the mean dosage 
of colloids was higher in the before-group. Norepinephrine 
was used less frequently in the before-group compared to the 
after-group (148 vs. 181 patients; 69% vs. 94%; p < 0.001), 
while the contrary was true for phenylephrine: (66 vs. 30 
patients; 31% vs. 16%; p < 0.001). However, no difference 
in the mean administered dosages of norepinephrine and 
phenylephrine between both groups was observed (Table 1).
3.3  Postoperative complications
Expectedly, implementation of the pGDT protocol was asso-
ciated with a reduction in the total sum of complications 
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(n = 414 in the before group vs. n = 282 in the after group, 
p = 0.031; Table 2, meaning that the complication rate per 
patient, decreased from 1.93 complications per patient in the 
before-group to 1.46 complications per patient in the after-
group. The cumulative complication score was also lower 
in the after-group compared to the before-group (3.0 vs. 4.4 
respectively; p = 0.009). Stratifying complications based on 
severity showed no difference for mild or moderate compli-
cations between the before and after-group (p = 0.311 and 
p = 0.177, respectively) (Table 2). However, the number of 
severe complications was reduced in the after-group compared 
to the before-group (n = 95 vs. n = 47 respectively, p = 0.003), 
meaning that the complication rate per patient reduced from 
0.44 to 0.24. The number of severe complications requiring 
an invasive procedure without general anesthesia was also 
reduced, from 37 to 14 respectively (p = 0.006; rate per patient 
0.17 (before-group) to 0.07 (after group). However, the occur-
rence of organ failure and postoperative death did not differ 
between groups, which was also true for the number of severe 
complications requiring a re-intervention under general anes-
thesia (Table 2).
3.4  Protocol compliance
Of the procedures in which pGDT was used, 79 procedures 
(42%) reached high protocol compliance for SVV or SVI 
(Table 3), while only 39 (21%) of the 188 procedures reached 
high protocol compliance for the CI target (Table 4). Proce-
dures with a high compliance for the either the SVV or SVI 
target were associated with a lower occurrence of postopera-
tive complications compared to procedures with low protocol 
compliance (OR 0.45; 95% CI 0.25–0.84). High SVV or SVI 
compliance was also associated with a reduction in mild/mod-
erate (n = 149 vs. n = 74; p = 0.023) and severe complications 
(n = 34 vs. n = 13; p = 0.015) compared to low protocol com-
pliance. In addition, the cumulative complications score was 
reduced in procedures with high compliance (3.54 vs. 2.29; 
p = 0.005) (Table 3). The total number of complications was 
reduced by 34% in procedures with high SVV or SVI compli-
ance (90 vs. 187; p = 0.01) (Fig. 3). No differences were found 
for postoperative death between high and low protocol com-
pliance for SVV or SVI. No differences in the occurrence or 
number of complications or postoperative death were observed 
between high and low compliance for the CI target.
Fig. 2  Flowchart of the inclusion of patients
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4  Discussion
In this before-and-after study, implementation of a pGDT 
protocol was associated with a reduction in postoperative 
complications in patients undergoing HRS. Importantly, high 
compliance with the SVV and SVI section of the pGDT pro-
tocol was associated with a further reduction in mild, moder-
ate and severe postoperative complications. Our study shows 
that in order to improve postoperative outcomes after the 
implementation of pGDT protocols, it is relevant to assess 
and increase protocol compliance of the attending caregivers. 
4.1  Reduction of postoperative complications
It was not unexpected that the implementation of our pGDT 
protocol was associated with a reduction in the incidence 
of postoperative complications. The observation of an 
improvement in postoperative patient outcomes following 
pGDT protocol implementation is in accordance with those 
of several systematic reviews with meta-analysis [2, 26]. In 
these systematic reviews, most often gastrointestinal surgery 
was assessed. We restricted our analysis to five surgical 
procedures that are performed frequently in our institution. 
Furthermore, to the best of our knowledge, there were no 
concurrent quality improvement projects for patients under-
going these procedures.
While many studies have shown that pGDT implementa-
tion results in lower postoperative morbidity [15, 27–29], 
this is not per se self-evident. In one study with similarities 
to our study, i.e., a quality improvement program to evalu-
ate a pGDT protocol in esophageal surgical procedures, no 
reduction was found regarding overall morbidity, length of 
Table 1  Characteristics and perioperative data of patients included before and after implementation of a perioperative goal-directed therapy pro-
tocol. Values are mean (SD), median [IQR] or number (proportion)
Given is the number or number (percentage)
BMI body mass index, ASA American Society of Anesthesiology, PPPD pylorus-preserving pancreaticoduodenectomy, APR abdominoperineal 
resection, AAA  abdominal aorta aneurysm, RBC red blood cells






Age (years) 66 (10.7) 66 (11.1) 0.66
Sex (male) 138 (64%) 122 (63%) 0.79
BMI (kg  m− 2) 26.4 (5.4) 26.5 (4.4) 0.77
ASA classification ASA 1 11 (5%) 21 (11%) 0.017
ASA 2 116 (54%) 98 (50%)
ASA 3 78 (36%) 73 (38%)
ASA 4 9 (4%) 1 (1%)
Included types of surgery PPPD 48 (22%) 48 (25%) 0.97
APR 62 (29%) 57 (30%)
Open AAA 31 (15%) 25 (13%)
Esophagus resection 25 (12%) 22 (11%)
Femoral-popliteal bypass surgery 48 (22%) 41 (21%)
Procedure duration; min 300 [210–450] 336 [242–469] 0.046
Blood loss; mL 500 [150–1050] 700 [250–1300] 0.026
Urine production; mL 520 [300–900] 680 [350–1000] 0.047
Crystalloids used 200 183 1.000
Crystalloid rate (mL  kg− 1 min− 1) 0.17 [0.12–0.24] 0.17 [0.13–0.22] 0.64
Colloids used 111 109 0.42
Colloid rate (mL  kg− 1 min− 1) 0.03 [0.02–0.06] 0.03 [0.02–0.04] 0.021
Packed RBC used 40 42 0.48
Packed RBC (mL  kg− 1 min− 1) 0.03 [0.02–0.04] 0.02 [0.01–0.04] 0.17
Norepinephrine used 148 181 < 0.001*
Norepinephrine dose (µg  kg− 1 min− 1) 0.08 [0.04–0.13] 0.06 [0.03–0.1] 0.009
Phenylephrine used 66 (31) 30 (16) < 0.001*
Dobutamine used 5 (2) 30 (16) < 0.001*
Dobutamine dose (µg  kg− 1 min− 1) 3.11 [0.17–8.28] 2.35 [1.28–3.88] 1.000
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hospital stay, or mortality [16]. However, the authors of 
that study mainly included patients undergoing minimally 
invasive laparoscopic esophagectomies, which are associ-
ated with fewer postoperative complications compared to 
open transthoracic esophagectomies [30]. In our study, only 
open esophagectomies were included, which may explain 
the conflicting results regarding the influence of pGDT on 
postoperative complications.
Table 2  The number of 
postoperative complications 
in patients undergoing surgery 
before and after implementation 
of a perioperative goal-directed 
therapy protocol








Patients with complications 154 (72%) 124 (64%) 0.10
Mild/moderate complications Mild 119 95 0.31
Moderate 188 133 0.18
Total complications 307 228 0.097
Severe complications Invasive procedure/no GA* 37 14 0.006*
Invasive procedure/GA 43 25 0.07
Organ failure 15 8 0.16
Total complications 95 47 0.003*
(Postoperative) death 12 (6%) 7 (4%) 0.34
Total complications Sum of complications 414 282 0.031*
(including death) Cumulative complication score 4.4 3.0 0.009*
Fig. 3  The association between 
protocol compliance based on 
SVV and SVI, and the total 
number of postoperative com-
plications. * p = 0.01
Table 3  The number of 
postoperative complications 
in patients undergoing surgery 
based on compliance with 
stroke volume variation/stroke 
volume index
Data is given as number or number (percentage)
SVV stroke volume variation, SVI stroke volume index
*p-values of 0.05 or lower are deemed significant
Low compliance with 
SVV or SVI
(n = 109)




Patients with complications 79 (72%) 43 (54%) 0.011*
Mild/moderate complications 149 74 0.023*
Severe complications 34 13 0.015*
Total number of complications 187 90 0.01*
Cumulative complication score 3.54 2.29 0.005*
60-day death postoperatively 4 (4%) 3 (4%) 0.964
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Regarding vasoactive agents, norepinephrine and dobu-
tamine were used more frequently in the after-group, while 
usage of phenylephrine was reduced. The increased dobutamine 
usage may be due to our protocols recommending dobutamine 
to increase CI if patients are no longer fluid responsive.
4.2  Influence of protocol compliance 
on complication incidence
The primary aim of our study was to assess whether com-
pliance with a pGDT protocol was associated with post-
operative outcomes. We found that high compliance (i.e., 
> 85% of the time) for the SVV and SVI-based algorithm 
was associated with a lower overall complication rate, with 
a lower number of mild, moderate, and severe complications. 
Interestingly though, no statistically significant differences 
in complication rate or postoperative death between the pro-
cedures with high and low compliance for the CI target were 
found, probably due to a low percentage of patients in which 
the CI targets were achieved.
Our results show that in only 46% of procedures, high 
protocol compliance with SVV/SVI was achieved and that 
this was true in only 24% of the patients regarding the CI 
targets. Multiple explanations exist for these rather low 
protocol compliance rates. Regarding SVV/SVI, low pro-
tocol compliance could be a consequence of hemodynamic 
instability during the operation, e.g. by blood loss. Since a 
fluid challenge is performed in 10 minutes and may need 
to be repeated before SVV or SVI is within their respec-
tive targets, protocol compliance could drop below the 85% 
cut-off point while still performing the protocol correctly. 
Also, attention to our protocol could be hampered by, for 
example, other intraoperative events requiring intervention. 
Additionally, caregivers may have based their hemodynamic 
management for individual patients on non-algorithm based 
individual preferences.
The even lower compliance with the CI target (only 24% 
of patients achieved the target CI) could be explained by the 
fact that the pGDT algorithm prioritizes SVV (pGDT 1) or 
SVI (pGDT 2) over CI. Both treatment algorithms recom-
mend targeting and improving SVV or SVI first, and con-
sidering dobutamine only after SVV or SVI was optimized 
or when the patient was considered fluid unresponsive. The 
more “secondary” place of CI in these treatment algorithms 
could have resulted in CI being considered less important 
compared to SVV or SVI—and it may have resulted in a 
delay in optimizing CI. Another reason might be that our 
anesthesiologists were not comfortable with administering 
dobutamine to increase CI in patients undergoing abdominal 
surgery, or they could have been afraid of side effects such 
as tachycardia and arrhythmias. Although dobutamine was 
used more frequently in the after-group, it was still only 
used in a minority (16%) of patients. In addition, it must be 
realized that although SVI and CI are more physiologically 
linked than SVV and SVI are, we bundled the compliance 
analysis for SVV and SVI on one hand, and CI on the other 
hand, since it was our aim to predominantly assess the com-
pliance of caregivers to both treatment algorithms irrespec-
tive of the exact hemodynamic variables that were used.
4.3  Implications and generalizability
Before-after studies show the effects of implementing a pro-
tocol more realistically than a randomized controlled trial. 
Nevertheless, this type of research has the disadvantage that 
confounders potentially influence results [19]. Protocol com-
pliance as confounder has been studied in other areas of 
perioperative and postoperative research, which have shown 
that higher protocol compliance leads to better patient out-
comes [9, 31, 32]. However, few studies have investigated 
the influence that protocol compliance could have on the 
occurrence of postoperative complications [33]. An addi-
tional disadvantage of before-after evaluation is the difficulty 
to relate interventions to the effects on a patient’s periopera-
tive physiological response. Using intervention-based proto-
col compliance could enable us to record a patient’s response 
to a specific intervention and determine what causes lower 
protocol compliance. Therefore, the results of our study 
could be considered a first impression of the influence of 
pGDT protocol compliance on patient outcomes.
4.4  Limitations
Our study has several limitations. First, as we intentionally 
selected a limited number of HRS procedures, our findings 
cannot be generalized to other interventions. Second, our 
pGDT protocol was introduced as an addition to current 
standard practice for anesthesiologists and was not prioritized 
over other institutional protocols used during the procedure. 
Table 4  The number of complications in patients undergoing surgery 
based on compliance with cardiac index










Patients with complications 99 (66%) 23 (59%) 0.39
Mild/moderate complications 181 42 0.41
Severe complications 39 8 0.78




60-day death postoperatively 6 (4%) 1 (3%) 0.67
Journal of Clinical Monitoring and Computing 
1 3
While this may have affected pGDT protocol compliance, it 
does provide a more realistic view of a perioperative setting 
in which multiple protocols are being used simultaneously. 
Third, our pGDT protocol focused mainly on the intraopera-
tive period. Hemodynamic changes and their treatment in the 
early postoperative period (ICU or post-anesthetic care unit) 
could have modified the outcome effects of our hemodynamic 
optimization efforts. Of note, the low compliance rate for 
CI that we observed, may “mask” a statistical association 
with postoperative outcome (i.e. a type II error), and a larger 
number of patients in whom CI compliance was sufficiently 
high may have given different results.
Finally, it cannot be excluded that a higher compliance 
was more easily reached in more “stable” patients, although 
this was not reflected by relevant data (e.g. there were no 
differences between low and high compliance with respect 
to ASA classification, surgery duration, or blood loss).
In summary, our study shows that if quality improvement 
is intended by the implementation of perioperative goal-
directed therapy in patients undergoing high-risk surgery, 
it is of particular importance to monitor and achieve a high 
protocol compliance in order to fully optimize postoperative 
outcomes.
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